Abdominal Abscess
Welcome,         Profile    Billing    Logout  
 7 Companies   3 Products   3 Products   2 Mechanisms of Action   0 Trials   38 News 
  • ||||||||||  Invanz (ertapenem) / Merck (MSD)
    Trial completion, Phase classification, Trial completion date, Head-to-Head:  Antibiotics for Klebsiella Liver Abscess Study (clinicaltrials.gov) -  Aug 27, 2018   
    P4,  N=152, Completed, 
    Recruiting --> Completed | Phase classification: PN/A --> P4 | Trial completion date: Apr 2018 --> Jan 2018
  • ||||||||||  Invanz (ertapenem) / Merck (MSD)
    Trial primary completion date, Head-to-Head:  Antibiotics for Klebsiella Liver Abscess Study (clinicaltrials.gov) -  Apr 14, 2017   
    P=N/A,  N=152, Recruiting, 
    Recruiting --> Completed Trial primary completion date: Aug 2015 --> Dec 2017
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis (clinicaltrials.gov) -  Jun 29, 2016   
    P=N/A,  N=244, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=200 --> 244 | Trial primary completion date: Feb 2016 --> May 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Prevalence of Colon Cancer in Pyogenic Liver Abscess (clinicaltrials.gov) -  Mar 1, 2016   
    P4,  N=62, Completed, 
    Recruiting --> Completed | N=200 --> 244 | Trial primary completion date: Feb 2016 --> May 2016 Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Feb 2016
  • ||||||||||  ceftriaxone / Generic mfg., moxifloxacin intravenous / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess (clinicaltrials.gov) -  Dec 5, 2015   
    P4,  N=24, Completed, 
    Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Feb 2016 Recruiting --> Completed | N=48 --> 24 | Trial primary completion date: Apr 2012 --> Dec 2010
  • ||||||||||  Phase classification, Trial initiation date, Trial primary completion date:  Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis (clinicaltrials.gov) -  Aug 12, 2015   
    P=N/A,  N=200, Active, not recruiting, 
    Initiation date: Aug 2012 --> Apr 2012 Phase classification: P4 --> P=N/A | Initiation date: Mar 2012 --> Aug 2012 | Trial primary completion date: Jul 2015 --> Feb 2016
  • ||||||||||  Enrollment closed, Trial primary completion date:  Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis (clinicaltrials.gov) -  Apr 20, 2015   
    P4,  N=214, Active, not recruiting, 
    Phase classification: P4 --> P=N/A | Initiation date: Mar 2012 --> Aug 2012 | Trial primary completion date: Jul 2015 --> Feb 2016 Completed --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Sep 2015
  • ||||||||||  Trial primary completion date:  Prevalence of Colon Cancer in Pyogenic Liver Abscess (clinicaltrials.gov) -  Apr 14, 2015   
    P4,  N=62, Recruiting, 
    Completed --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Sep 2015 Trial primary completion date: Jun 2015 --> Jun 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Treatment of Abdominal Abscesses With or Without Fibrinolysis (clinicaltrials.gov) -  Feb 5, 2015   
    P=N/A,  N=92, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Mar 2013 --> Jan 2014
  • ||||||||||  Trial completion, Trial primary completion date:  Laparoscopic Management of Periappendicular Abscess (clinicaltrials.gov) -  Sep 28, 2014   
    P2,  N=60, Completed, 
    Recruiting --> Completed | Trial primary completion date: Mar 2013 --> Jan 2014 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2014
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis (clinicaltrials.gov) -  Jul 16, 2014   
    P4,  N=214, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2014 Enrolling by invitation --> Completed | N=3000 --> 214 | Trial primary completion date: Jul 2014 --> Mar 2014
  • ||||||||||  Enrollment open:  Prevalence of Colon Cancer in Pyogenic Liver Abscess (clinicaltrials.gov) -  Jan 20, 2014   
    P4,  N=62, Recruiting, 
    Trial completion date: May 2014 --> Dec 2014 Active, not recruiting --> Recruiting
  • ||||||||||  Trial termination:  Safety and Effectiveness of tPA in Intra-abdominal Abscesses (clinicaltrials.gov) -  Jan 12, 2014   
    P2/3,  N=35, Terminated, 
    Active, not recruiting --> Recruiting Recruiting --> Terminated; Change in patient population no longer fit study criteria.
  • ||||||||||  Enrollment change:  Safety and Effectiveness of tPA in Intra-abdominal Abscesses (clinicaltrials.gov) -  Jan 12, 2014   
    P2/3,  N=35, Terminated, 
    Recruiting --> Terminated; Change in patient population no longer fit study criteria. N=100 --> 35
  • ||||||||||  Invanz (ertapenem) / Merck (MSD)
    Trial initiation date, Head-to-Head:  Antibiotics for Klebsiella Liver Abscess Study (clinicaltrials.gov) -  Dec 1, 2013   
    P=N/A,  N=152, Recruiting, 
    N=100 --> 35 Initiation date: Jan 2013 --> Nov 2013
  • ||||||||||  Invanz (ertapenem) / Merck (MSD)
    Enrollment open, Head-to-Head:  Antibiotics for Klebsiella Liver Abscess Study (clinicaltrials.gov) -  Dec 1, 2013   
    P=N/A,  N=152, Recruiting, 
    Initiation date: Jan 2013 --> Nov 2013 Not yet recruiting --> Recruiting